Citation Payola?

A transgenic mouse company is paying researchers who mention its animal models in scientific papers.

By | August 18, 2015

FLICKR, MIKE SCHMIDCompanies of all stripes frequently flood customer inboxes with special email offers. But a deal offered by Cyagen Biosciences, which provides transgenic mice among other products and services to life-science researchers, has raised hackles across the Internet. The California-based company sent out an email offer that encouraged researchers to mention Cyagen in the methods sections of published papers, promising store credit to willing scientists; authors could get $100 × the journal’s impact factor (IF) for citing the company in their papers.

Cyagen apparently began sending out the email offer in June, but last week, researchers lit up Twitter with outraged reactions to the deal. “Cyagen Biosciences offers $100 in rewards or more if high IF for citing them in your publication! Outrageous!” tweeted Oregon State University geneticist Niklaus Grunwald. The marketing ploy garnered significant attention on Friday (August 14), when Ben Goldacre excoriated Cyagen on his blog. “I would imagine that this is something journal editors will be interested in, and concerned by,” he wrote. “We worry about ‘conflict of interest’ a lot in science, and especially medicine: if someone has shares in a company, or receives money from it, and their publication discusses that company’s products, then this needs to be declared in the paper. If you get funding for a study then, again, you must declare it. If you have received payment for making an academic citation, then in my view this is clearly a source of funds that should be declared.” Later in the post Goldacre linked to Cyagen’s citations page, which contains references to 164 papers that cite the company for the use of their animal models.

Cyagen spokesperson Austin Jelcick downplayed the Internet furor. The deal involves store credit, not cash, he told Science. And that voucher is not for citations, but for mentions of the company in methods sections, which would likely happen anyway. Some of the authors on the list of 164 papers expressed similar sentiments. “I do not see a conflict of interest,” developmental biologist Vincent Christoffels of the University of Amsterdam in The Netherlands wrote in an email to Science. “In my opinion this is not different from any other discount you often get when buying lab equipment, antibodies, transgenic services etc. Just makes science a little less expensive.”

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Michael Jakowec

Michael Jakowec

Posts: 1

August 20, 2015

Antibody production companies have been conducting a similar policy for the last 25 years where they offer credit if their antiboidies are cited. I doubt $100  credit is enough to corrupt the average bench scientist. If anythoing it may identify reagents that actually work.

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip